Authors: Qian, CG Hwang, SB Libertine-Garahan, L Eckman, JB Cai, X Scannell, RT Yeh, CG

Citation: Cg. Qian et al., Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor, PHARMAC RES, 44(3), 2001, pp. 213-220

Authors: Kroshus, TJ Salerno, CT Yeh, CG Higgins, PJ Bolman, RM Dalmasso, AP

Citation: Tj. Kroshus et al., A recombinant soluble chimeric complement inhibitor composed of human CD46and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation, TRANSPLANT, 69(11), 2000, pp. 2282-2289

Authors: Birmingham, DJ Hebert, LA Shen, XP Higgins, P Yeh, CG Creasey, AA

Citation: Dj. Birmingham et al., Effects of immune complex formation and complement activation on circulating platelets in the primate, CLIN IMMUNO, 91(1), 1999, pp. 99-105

Authors: Cai, X Chorghade, MS Fura, A Grewal, GS Jauregui, KA Lounsbury, HA Scannell, RT Yeh, CG Young, MA Yu, SX Guo, L Moriarty, RM Penmasta, R Rao, MS Singhal, RK Song, ZZ Staszewski, JP Tuladhar, SM Yang, SM

Citation: X. Cai et al., Synthesis of CMI-977, a potent 5-lipoxygenase inhibitor, ORG PROC R, 3(1), 1999, pp. 73-76

Authors: Rinder, CS Rinder, HM Johnson, K Smith, M Lee, DL Tracey, J Polack, G Higgins, P Yeh, CG Smith, BR

Citation: Cs. Rinder et al., Role of C3 cleavage in monocyte activation during extracorporeal circulation, CIRCULATION, 100(5), 1999, pp. 553-558